Skip Navigation

European Heart Journal 2000 21(1):17-27; doi:10.1053/euhj.1999.1698
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Berger, R.M.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, R.M.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects

R.M.F. Bergerf1

Department of Pediatrics, Division of Pediatric Cardiology, Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, The Netherlands

f1 Correspondence: R. M. F. Berger, MD, PhD, Department of Pediatrics, Division of Pediatric Cardiology, Sophia Children's Hospital/University Hospital Rotterdam, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands. (P. O. Box 2060, 3000 CB, Rotterdam, The Netherlands.)

References

  1. Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Cremona G, Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol. 1989;99:9–10[Web of Science]
  2. Collins-Nakai RL, Rabinovitch M. Pulmonary vascular obstructive disease. Cardiol Clin. 1993;11:675–687[Medline]
  3. Hoffman JI, Rudolph AM, Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation. 1981;64:873–877[Abstract/Free Full Text]
  4. Haworth SG. Pulmonary hypertension in childhood. Eur Respir J. 1993;6:1037–1043[Abstract]
  5. Morin FC III, Stenmark KR. Persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med. 1995;151:2010–2032[Web of Science][Medline]
  6. Rabinovitch M. Pulmonary hypertension: updating a mysterious disease. Cardiovasc Res. 1997;34:268–272[Free Full Text]
  7. Reuben SR. Compliance of the human pulmonary arterial system in disease. Circ Res. 1971;29:40–50[Abstract/Free Full Text]
  8. Madden JA, Keller PA, Effros RM, Seavitte C, Choy JS, Hacker AD. Responses to pressure and vasoactive agents by isolated pulmonary arteries from monocrotaline-treated rats. J Appl Physiol. 1994;76:1589–1593[Abstract/Free Full Text]
  9. Wagenvoort CA. Open lung biopsies in congenital heart disease for evaluation of pulmonary vascular disease. Predictive value with regard to corrective operability. Histopathology. 1985;9:417–436[Web of Science][Medline]
  10. Ivy DD, Neish SR, Abman SH. Regulation of the pulmonary circulation. Garson A Jr, Bricker JT, Fisher DJ, Neish SR. The Science and Practice of Pediatric Cardiology. Baltimore: Williams and Wilkins; 1998. p. 329–347
  11. Rabinovitch M. Problems of pulmonary hypertension in children with congenital cardiac defects. Chest. 1988;93:119S–126S[Free Full Text]
  12. Surawicz B. Electrocardiographic diagnosis of chamber enlargement. J Am Coll Cardiol. 1986;8:711–724[Abstract]
  13. Zellers T, Gutgesell HP. Nonivasive estimation of pulmonary artery pressure. J Pediatr. 1989;114:735–741[CrossRef][Web of Science][Medline]
  14. Isobe M, Yazaki Y, Takaku F. Prediction of pulmonary arterial pressure in adults by pulsed Doppler echocardiography. Am J Cardiol. 1986;57:316–321[CrossRef][Web of Science][Medline]
  15. Martin-Duran R, Larman M, Trugeda A, Vazquez de Prada JA, Ruano J. Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization. Am J Cardiol. 1986;57:859–863[CrossRef][Web of Science][Medline]
  16. Matsuda M, Sekiguchi T, Sugishita Y, Kuwako K, Iida K, Ito I. Reliability of non-invasive estimates of pulmonary hypertension by pulsed Doppler echocardiography. Br Heart J. 1986;56:158–164[Abstract/Free Full Text]
  17. Rebergen SA, Ottenkamp J, Doornbos J, van der Wall EE, Chin JG, de Roos A. Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol. 1993;21:123–131[Abstract]
  18. Be'eri E, Maier SE, Landzberg MJ, Chung T, Geva T. In vivo evaluation of Fontan pathway flow dynamics by multidimensional phase-velocity magnetic resonance imaging. Circulation. 1998;98:2873–2882[Abstract/Free Full Text]
  19. Evans AJ, Iwai F, Grist TA. Magnetic resonance imaging of blood flow with a phase subtraction technique: in vitro and in vivo validation. Invest Radiol. 1993;28:109–115[CrossRef][Web of Science][Medline]
  20. Van Rossum AC, Sprenger M, Visser FC, Peels KH, Valk J, Roos JP. An in vivo validation of quantitative blood flow imaging in arteries and veins using magnetic resonance phase-shift techniques. Eur Heart J. 1991;12:117–126[Abstract/Free Full Text]
  21. Hundley WG, Li HF, Lange RA. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation. 1995;91:2955–2960[Abstract/Free Full Text]
  22. Bridges ND, Freed MD. Cardiac catheterization. Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP. Moss and Adams Heart Disease in infants, Children and Adolescents, Including the Fetus and Young Adult, 5th ed. Baltimore: Williams and Wilkins; 1995. p. 310–329
  23. Vargo TA. Cardiac catheterization. Garson A Jr, Bricker JT, Fisher DJ, Neish SR. The Science and Practice of Pediatric Cardiology. Baltimore: Williams and Wilkins; 1998. p. 961–993
  24. Lock JC, Keane JF, Fellows KE. Diagnostic and interventional catheterization in congenital heart disease. Boston: Martinus Nijhoff; 1987.
  25. Schostal SJ, Krovetz LJ, Rowe RD. An analysis of errors in conventional cardiac catheterization data. Am Heart J. 1972;83:596[CrossRef][Web of Science][Medline]
  26. Keane JF, Fyler DC, Nadas AS. Hazards of cardiac catheterization in children with primary vascular obstruction. Am Heart J. 1978;96:556–557[CrossRef][Web of Science][Medline]
  27. Rudolph AM. Cardiac catheterization and angiocardiography. Rudolph AM. Congenital Diseases of the Heart. Chicago: Year Book Medical Publishers, Inc; 1974. p. 49–167
  28. Pitton MB, Duber C, Doz P, Mayer E, Thelen M. Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1996;94:2485–2491[Abstract/Free Full Text]
  29. Cassidy SC, Schmidt KG, Van Hare GF, Teitel DF. Complications of pediatric cardiac catheterization: a 3-year study. J Am Coll Cardiol. 1992;19:1285–1293[Abstract]
  30. West JB. Blood Flow. New York: Academic Press; 1977.
  31. Stewart GN. Researches on the circulation time and on the influences which affect it. J Physiol. 1897;22:159–183
  32. Cournand A, Riley RL, Breed ES. Measurement of cardiac output in man using the technique of catheterisation of the right auricle or ventricle. J Clin Invest. 1945;24:106–116
  33. French WJ, Chang PS, Criley JM. Estimation of mixed venous oxygen saturation. Cathet Cardiovasc Diagn. 1983;9:25–31[Web of Science][Medline]
  34. Dexter L, Haynes FW, Burwell CS, Eppinger CE, Sagerson RP, Evans JM. Studies of congenital heart disease, II. The pressure and oxygen content in blood in the right auricle, right ventricle, and pulmonary artery in control patients, with observations on the oxygen saturation and source of pulmonary ‘capillary’ blood. J Clin Invest. 1947;26:554–560
  35. Freed MD, Miettinen OS, Nadas AS. Oximetric detection of intracardiac left-to-right shunts. Br Heart J. 1979;42:690–694[Free Full Text]
  36. Hillis LD, Firth BG, Winniford MD. Variability of right-sided cardiac oxygen saturations in adults with and without left-to-right intracardiac shunting. Am J Cardiol. 1986;58:129–132[CrossRef][Web of Science][Medline]
  37. Pirwitz MJ, Willard JE, Landau C, Hillis LD, Lange RA. A critical reappraisal of the oximetric assessment of intracardiac left-to-right shunting in adults. Am Heart J. 1997;133:413–417[CrossRef][Web of Science][Medline]
  38. Boehrer JD, Lange RA, Willard JE, Grayburn PA, Hillis LD. Advantages and limitations of methods to detect, localize and quantitate intracardiac left-to-right shunting. Am Heart J. 1992;124:448–455[CrossRef][Web of Science][Medline]
  39. Shepherd AP, McMahan CA. Role of oximeter error in the diagnosis of shunts. Cathet Cardiovasc Diagn. 1996;37:435–446[CrossRef][Web of Science][Medline]
  40. Nelson LD, Anderson HB, Garcia H. Clinical validation of a new metabolic monitor suitable for use in critically ill patients. Crit Care Med. 1987;10:951–957
  41. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res. 1970;4:23–30[Abstract/Free Full Text]
  42. Berger R, van Poppelen R, Kruit M, van Vliet A, Witsenburg M, Hess J. Impact of discrepancy between assumed and measured oxygen consumption for the calculation of cardiac output in children during cardiac catheterisation. Neth J Cardiol. 1992;4:156–160
  43. Kappagoda CT, Greenwood P, Macartney FJ, Linden RJ. Oxygen consumption in children with congenital diseases of the heart. Clin Sci. 1973;45:107–111[Web of Science][Medline]
  44. Ultman JS, Bursztein S. Analysis of error in the determination of respiratory gas exchange at varying FiO2. J Appl Physiol. 1981;50:210–216[Abstract/Free Full Text]
  45. Broadbent JC, Wood EH. Indicator dilution curves in acyanotic congenital heart disease. Circulation. 1954;9:890–902[Web of Science][Medline]
  46. Hamilton WF, Moore JW, Kinsman JM, Spurling RG. Studies on the circulation IV. Further analysis of the injection method and of changes in hemodynamics under physiological and pathological conditions. Am J Physiol. 1932;99:534[Free Full Text]
  47. Mook GA, Zijlstra WG. Quantitative evaluation of intracardiac shunts from arterial dye dilution curves. Demonstration of very small shunts. Acta Med Scand. 1961;170:703–715[Web of Science][Medline]
  48. Cohn JD, Del Guercio RM. Clinical applications of indicator dilution curves as gamma functions. J Lab Clin Med. 1967;69:675–682[Web of Science][Medline]
  49. Thompson HK, Starmer FC, Whalen RE, McIntosh HD. Indicator transit time considered as a gamma variate. Circ Res. 1964;14:502–515[Free Full Text]
  50. Carter SA, Bajec DF, Yannicelli E, Wood EH. Estimation of left-to-right shunt from arterial dilution curves. J Lab Clin Med. 1960;55:77–88[Web of Science][Medline]
  51. McIlveen BM, Murray IP, Giles RW, Molk GH, Scarf CM, McCredie RM. Clinical application of radionuclide quantitation of left-to-right cardiac shunts in children. Am J Cardiol. 1981;47:1273–1278[CrossRef][Web of Science][Medline]
  52. Castillo CA, Kyle JC, Gilson WE, Rowe GG. Simulated shunt curves. Am J Cardiol. 1966;17:691–694[CrossRef][Web of Science][Medline]
  53. Niggemann EH, Ma PT, Sunnergren KP, Winniford MD, Hillis LD. Detection of intracardiac left-to-right shunting in adults: a prospective analysis of the variability of the standard indocyanine green technique in patients without shunting. Am J Cardiol. 1987;60:355–357[CrossRef][Web of Science][Medline]
  54. Dehmer GJ, Rutala WA. Current use of green dye curves. Am J Cardiol. 1995;75:170–171[CrossRef][Web of Science][Medline]
  55. Hillis LD, Winniford MD, Jackson JA, Firth BG. Measurements of left-to-right intracardiac shunting in adults: oximetric versus indicator dilution techniques. Cathet Cardiovasc Diagn. 1985;11:467–472[Web of Science][Medline]
  56. Daniel WC, Lange RA, Willard JE, Landau C, Hillis LD. Oximetric versus indicator dilution techniques for quantitating intracardiac left-to-right shunting in adults. Am J Cardiol. 1995;75:199–200[CrossRef][Web of Science][Medline]
  57. Prandtl L, Tietjens OG. Applied Hydro- and Aeromechanics. New York: Dover Publications, Inc; 1957.
  58. Hoffman J. Diagnosis and treatment of pulmonary vascular disease. Birth Defects. 1972;8:9–18
  59. Sniderman AD, Fitchett DH. Vasodilators and pulmonary hypertension: the paradox of therapeutic success and clinical failure. Int J Cardiol. 1988;20:173–181[CrossRef][Web of Science][Medline]
  60. Bush A, Busst CM, Haworth SG. Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. Br Heart J. 1988;59:480–485[Abstract/Free Full Text]
  61. Bush A, Busst C, Knight WB, Shinebourne EA. Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy. Am Rev Respir Dis. 1987;136:767–769[Web of Science][Medline]
  62. Berner M, Beghetti M, Spahr-Schopfer I, Oberhansli I, Friedli B. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol. 1996;77:532–535[CrossRef][Web of Science][Medline]
  63. Barst RJ, Rubin LJ, Long WA. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296–301[Abstract/Free Full Text]
  64. McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 1998;338:273–277[Abstract/Free Full Text]
  65. Fishman AP. Pulmonary hypertension: Beyond vasodilator therapy. N Engl J Med. 1998;338:321–322[Free Full Text]
  66. Heath D, Edwards J. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958;18:533–547[Web of Science][Medline]
  67. Wagenvoort CA, Wagenvoort N. Pathology of Pulmonary Hypertension. New York: J Wiley and Sons; 1977.
  68. Wagenvoort CA. Grading of pulmonary vascular lesions—a reappraisal. Histopathology. 1981;5:595–598[Web of Science][Medline]
  69. Wagenvoort CA, Mooi WJ. Biopsy Pathology of the Pulmonary Vasculature. London: Chapman and Hall Medical; 1989.
  70. Wagenvoort CA, Wagenvoort N, Draulans-Noë Y. Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery. J Thorac Cardiovasc Surg. 1984;87:876–886[Abstract]
  71. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation. 1978;58:1107–1122[Abstract/Free Full Text]
  72. Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation. 1984;69:655–667[Abstract/Free Full Text]
  73. Braunlin EA, Moller JH, Patton C, Lucas RV Jr, Lillehei CW, Edwards JE. Predictive value of lung biopsy in ventricular septal defect: long term follow-up. J Am Coll Cardiol. 1986;5:1113–1118
  74. Wilson NJ, Seear MD, Taylor GP, LeBlanc JG, Sandor GGS. The clinical value and risks of lung biopsy in children with congenital heart disease. J Thorac Cardiovasc Surg. 1990;99:460–468[Abstract]
  75. Reid LM. Structure and function in pulmonary hypertension. New perceptions. Chest. 1986;89:279–288[Free Full Text]
  76. Haworth SG. Pathophysiological and metabolic manifestations of pulmonary vascular disease in children. Herz. 1992;17:254–261[Web of Science][Medline]
  77. Haworth SG. Understanding pulmonary vascular disease in young children. Int J Cardiol. 1987;15:101–103[CrossRef]
  78. Haworth SG, Reid L. A morphometric study of regional variation in lung structure in infants with pulmonary hypertension and congenital cardiac defect. A justification of lung biopsy. Br Heart J. 1978;40:825–831[Abstract/Free Full Text]
  79. Reid L. Lung growth in health and disease. Br J Dis Chest. 1984;78:113–134[Web of Science][Medline]
  80. Haworth SG, Sauer U, Buhlmeyer K, Reid L. Development of the pulmonary circulation in ventricular septal defect: a quantitative structural study. Am J Cardiol. 1977;40:781–788[CrossRef][Web of Science][Medline]
  81. Gorenflo M, Vogel M, Hetzer R. Morphometric techniques in the evaluation of pulmonary vascular changes due to congenital heart disease. Path Res Pract. 1996;192:107–116
  82. Mooi WJ, Wagenvoort CA. Decreased numbers of pulmonary blood vessels: reality or artefact. J Pathol. 1983;141:441–447[CrossRef][Web of Science][Medline]
  83. Bell AL, Shimomura S, Guthrie WJ, Hempel HF, Fitzpatrick HF, Begg CF. Wedge pulmonary arteriography. Its application in congenital and acquired heart disease. Radiology. 1959;73:566[Web of Science][Medline]
  84. Nihill MR, McNamara DG. Magnification pulmonary wedge angiography in the evaluation of children with congenital heart disease and pulmonary hypertension. Circulation. 1978;58:1094–1106[Free Full Text]
  85. Rabinovitch M, Keane JF, Fellows KE, Castaneda AR, Reid L. Quantitative analysis of the pulmonary wedge angiogram in congenital heart defects. Correlation with hemodynamic data and morphometric findings in lung biopsy tissue. Circulation. 1981;63:152–164[Free Full Text]
  86. Wilson NJ, Culham JAG, Sandor GGS, Taylor GP. Pulmonary wedge angiography for prediction of pulmonary vascular disease in Down syndrome. Cathet Cardiovasc Diagn. 1993;28:22–33[Web of Science][Medline]
  87. Spencer MP, Denison AB Jr. Pulsatile blood flow in the vascular system. Hamilton WF, Dow P. Handbook of Physiology. Baltimore, Maryland: Williams and Wilkins Company; 1963. p. 839–864
  88. De Canniere D, Stefanidis C, Brimioulle S, Naeije R. Effects of a chronic aortopulmonary shunt on pulmonary hemodynamics in piglets. J Appl Physiol. 1994;77:1591–1596[Abstract/Free Full Text]
  89. Chen EP, Bittner HB, Davis RD, Van Trigt P. Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension. J Surg Res. 1997;69:288–294[CrossRef][Web of Science][Medline]
  90. Chen EP, Bittner HB, Tull F, Craig D, Davis RD, Van Trigt P. Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertension. J Thorac Cardiovasc Surg. 1997;113:849–857[Abstract/Free Full Text]
  91. Berger RM, Cromme-Dijkhuis AH, Van Vliet AM, Hess J. Evaluation of the pulmonary vasculature and dynamics with intravascular ultrasound imaging in children and infants. Pediatr Res. 1995;38:36–41[Web of Science][Medline]
  92. Porter TR, Taylor DO, Fields J. Direct in vivo evaluation of pulmonary arterial pathology in chronic congestive heart failure with catheter-based intravascular ultrasound imaging. Am J Cardiol. 1993;71:754–757[CrossRef][Web of Science][Medline]
  93. Haworth SG. Pulmonary vascular disease in ventricular septal defect: structural and functional correlations in lung biopsies from 85 patients, with outcome of intracardiac repair. J Pathol. 1987;152:157–168[CrossRef][Web of Science][Medline]
  94. Clabby ML, Canter CE, Moller JH, Bridges ND. Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Cardiol. 1997;30:554–560[Abstract]
  95. Choussat A, Fontan F, Besse P, Vallot F, Chauve A, Bricaud H. Selection criteria for Fontan procedure. Anderson RHSE. Paediatric Cardiology. Edinburgh: Churchill Livingstone; 1978.
  96. Senzaki H, Isoda T, Ishizawa A, Hishi T. Reconsideration of criteria for the Fontan operation. Influence of pulmonary artery size on postoperative hemodynamics of the Fontan operation. Circulation. 1994;89:1196–1202[Abstract/Free Full Text]
  97. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431–1438[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Muthurangu, D. Atkinson, M. Sermesant, M. E. Miquel, S. Hegde, R. Johnson, R. Andriantsimiavona, A. M. Taylor, E. Baker, R. Tulloh, et al.
Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1301 - H1306.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Muthurangu, A. Taylor, R. Andriantsimiavona, S. Hegde, M. E. Miquel, R. Tulloh, E. Baker, D. L.G. Hill, and R. S. Razavi
Novel Method of Quantifying Pulmonary Vascular Resistance by Use of Simultaneous Invasive Pressure Monitoring and Phase-Contrast Magnetic Resonance Flow
Circulation, August 17, 2004; 110(7): 826 - 834.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. M. F. Berger, A. H. Cromme-Dijkhuis, W. C. J. Hop, M. N. Kruit, and J. Hess
Pulmonary Arterial Wall Distensibility Assessed by Intravascular Ultrasound in Children With Congenital Heart Disease* : An Indicator for Pulmonary Vascular Disease?
Chest, August 1, 2002; 122(2): 549 - 557.
[Abstract] [Full Text] [PDF]


This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Berger, R.M.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, R.M.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?